Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

NCT01160172 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women

NCT01150123 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

NCT01453348 ·Status: COMPLETED ·Phase: PHASE3

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS

NCT04258995 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

NCT04645147 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

NCT07054099 ·Status: RECRUITING ·Phase: PHASE3

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.

NCT02459262 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

NCT06409494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age

NCT00657683 ·Status: COMPLETED ·Phase: PHASE1

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.

NCT02690181 ·Status: COMPLETED ·Phase: PHASE2

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

NCT02965404 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

NCT00707967 ·Status: COMPLETED ·Phase: PHASE2

Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

NCT00189943 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

NCT02270944 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

NCT05703607 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

NCT05701800 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

NCT00857493 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults

NCT00814489 ·Status: COMPLETED ·Phase: PHASE1

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

NCT03610581 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

NCT01147991 ·Status: COMPLETED ·Phase: PHASE1

Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

NCT00189969 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

NCT00534248 ·Status: COMPLETED ·Phase: PHASE3

ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

NCT01600079 ·Status: COMPLETED

Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

NCT00338442 ·Status: APPROVED_FOR_MARKETING

Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults

NCT00736476 ·Status: COMPLETED ·Phase: PHASE1